SEMENTIS LTD has a total of 47 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), United States and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are GENEIUS BIOTECHNOLOGY INC, IMMUNICUM AB and MEDIGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | China | 4 | |
#4 | Republic of Korea | 4 | |
#5 | Australia | 3 | |
#6 | Canada | 3 | |
#7 | Singapore | 3 | |
#8 | WIPO (World Intellectual Property Organization) | 3 | |
#9 | Hong Kong | 2 | |
#10 | Israel | 2 | |
#11 | Japan | 2 | |
#12 | New Zealand | 2 | |
#13 | Russian Federation | 2 | |
#14 | Argentina | 1 | |
#15 | Brazil | 1 | |
#16 | Chile | 1 | |
#17 | Hungary | 1 | |
#18 | Mexico | 1 | |
#19 | Serbia | 1 | |
#20 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Howley Paul Michael | 29 |
#2 | Liu Liang | 14 |
#3 | Howley Paul | 10 |
#4 | Paul Michael Howley | 3 |
#5 | Paul Howley | 2 |
#6 | Liang Liu | 1 |
#7 | Khauli Pol Majkl | 1 |
#8 | Lyu Lyan | 1 |
Publication | Filing date | Title |
---|---|---|
MX2019001919A | Viral vaccines. | |
IL245363D0 | Cell lines and processes for viral vector manufacture | |
EP3063278A1 | Viral vector manufacture | |
CA2906735A1 | Immune modulation |